Recorded Chinese product: 复方氯化钠注射液复方氯化钠注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

氯化钾C是一种在国家药监局注册认定的药品。该药品含有氯化钠、氯化钾c-22c01ac2等成分。

该药品关联的活性成分包括:氯化钠Lvhua Na、氯化钾c。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:浙江国镜药业有限公司Chinese legal name: 浙江国镜药业有限公司。

您可以探索含有相同成分的其他药品:氯化钠-ad5396cb成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 复方氯化钠注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 氯化钠Lvhua Na.

Manufacturers recorded for this product: 浙江国镜药业有限公司Chinese legal name: 浙江国镜药业有限公司.

Explore other medicines containing the same ingredient: 氯化钠 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 复方氯化钠注射液Recorded Chinese product: 复方氯化钠注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 500ml500 mL

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 浙江国镜药业有限公司Chinese legal name: 浙江国镜药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H33021556

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H33021556

Manufacturer

Chinese legal name: 浙江国镜药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H33021556

生产企业

浙江国镜药业有限公司(国产)

适应症

1. 各种原因所致的失水,包括低渗性、等渗性和高渗性失水。2. 高渗性非酮症昏迷,应用等渗或低渗氯化钠可纠正失水和高渗状态。3. 低氯性代谢性碱中毒。患者因某种原因不能进食或进食减少而需补充每日生理需要量时,一般可给予氯化钠注射液或复方氯化钠注射液等。因本品含钾量极少,低钾血症需根据需要另行补充。

用法用量

1? 静脉滴注,剂量视病情需要及体重而定。常用剂量,一次500~1000ml。2? 低氯性碱中毒,根据碱中毒量情况决定用量。

不良反应

1. 输注过多、过快,可致水钠潴留,引起水肿、血压升高、心率加快、胸闷、呼吸困难,甚至急性左心衰竭。2. 不适当地给予高渗氯化钠可致高钠血症。3. 过多、过快给予低渗氯化钠可致溶血、脑水肿等

禁忌

尚不明确。

注意事项

1. 下列情况慎用(1) 水肿性疾病,如肾病综合征、肝硬化、腹水、充血性心力衰竭、急性左心衰竭、脑水肿及特发性水肿等。(2) 急性肾功能衰竭少尿期,慢性肾功能衰竭尿量减少而对利尿药反应不佳者。(3) 高血压。(4) 低钾血症。2. 随访检查(1) 血清Na+、K+、Cl-浓度。(2) 血液酸碱平衡指标。(3) 肾功能。(4) 血压和心肺功能。

贮藏

密封保存。

规格

500ml

证据Evidence

  • 批准文号: 国药准字H33021556
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.